ImmuCell
Price & Volume
Stats
See more52W Range | $3.34-$5.82 |
Market Cap | $48.7M |
Shares Short | 4,465 |
Financials
See moreRevenue (12 Mos) | $26.4M |
Revenue Growth (YoY) | 52.1% |
Gross Profit (12 Mos) | $8.3M |
Diluted EPS | -$0.26 |
News
See moreYahoo Finance • 24 days ago
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025
Yahoo Finance • 30 days ago
ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®
Yahoo Finance • 2 months ago
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024
Yahoo Finance • 2 months ago
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024
About
CEO | Mr. Michael F. Brigham |
Address | 56 Evergreen Drive, Portland, ME, United States, 04103 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 69 |
